...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

I have dealt with the CRA and with my brokerage,,,last year!,,,after weeks of back and forth the answer was yes,,,,,,CRA agent said they would be right off the get go,,my brokerage at first said probably not,,(RBC),,,I went higher up and discussed and was given a wait and see time,,,,then they came back and said yes to the TFSA.

Share
New Message
Please login to post a reply